In Vivo Characterization of Tick-Borne Encephalitis Virus in Bank Voles (


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
15 11 2019
Historique:
received: 31 08 2019
revised: 07 11 2019
accepted: 13 11 2019
entrez: 17 11 2019
pubmed: 17 11 2019
medline: 17 9 2020
Statut: epublish

Résumé

Tick-borne encephalitis is the most important tick-transmitted zoonotic virus infection in Eurasia, causing severe neurological symptoms in humans. The causative agent, the tick-borne encephalitis virus (TBEV), circulates between ticks and a variety of mammalian hosts. To study the interaction between TBEV and one of its suspected reservoir hosts, bank voles of the Western evolutionary lineage were inoculated subcutaneously with either one of eight TBEV strains or the related attenuated Langat virus, and were euthanized after 28 days. In addition, a subset of four strains was characterized in bank voles of the Carpathian linage. Six bank voles were inoculated per strain, and were housed together in groups of three with one uninfected in-contact animal each. Generally, most bank voles did not show any clinical signs over the course of infection. However, one infected bank vole died and three had to be euthanized prematurely, all of which had been inoculated with the identical TBEV strain (Battaune 17-H9, isolated in 2017 in Germany from a bank vole). All inoculated animals seroconverted, while none of the in-contact animals did. Viral RNA was detected via real-time RT-PCR in the whole blood samples of 31 out of 74 inoculated and surviving bank voles. The corresponding serum sample remained PCR-negative in nearly all cases (29/31). In addition, brain and/or spine samples tested positive in 11 cases, mostly correlating with a positive whole blood sample. Our findings suggest a good adaption of TBEV to bank voles, combining in most cases a low virulence phenotype with detectable virus replication and hinting at a reservoir host function of bank voles for TBEV.

Identifiants

pubmed: 31731773
pii: v11111069
doi: 10.3390/v11111069
pmc: PMC6893798
pii:
doi:

Substances chimiques

Antibodies, Viral 0
RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

Clin Exp Immunol. 1997 Dec;110(3):358-61
pubmed: 9409636
Curr Opin Infect Dis. 2008 Oct;21(5):462-7
pubmed: 18725794
Emerg Microbes Infect. 2018 Apr 25;7(1):74
pubmed: 29691370
Emerg Infect Dis. 2017 Jan;23(1):83-86
pubmed: 27983499
Front Cell Infect Microbiol. 2018 Mar 22;8:90
pubmed: 29623261
J Virol. 2006 Feb;80(3):1427-39
pubmed: 16415020
Vector Borne Zoonotic Dis. 2008 Oct;8(5):713-20
pubmed: 18837668
J Gen Virol. 1999 Jan;80 ( Pt 1):179-85
pubmed: 9934700
Virus Res. 2012 Feb;163(2):660-6
pubmed: 22155022
Euro Surveill. 2018 Nov;23(45):
pubmed: 30424829
Zentralbl Bakteriol Orig. 1968;207(4):429-34
pubmed: 5754630
J Clin Virol. 2003 Jul;27(2):136-45
pubmed: 12829035
Front Bioeng Biotechnol. 2016 May 11;4:40
pubmed: 27243000
J Autoimmun. 2018 Mar;88:21-42
pubmed: 29183642
Mol Phylogenet Evol. 2015 Jan;82 Pt A:245-57
pubmed: 25450101
Lancet. 2008 May 31;371(9627):1861-71
pubmed: 18514730
J Virol. 2010 Jan;84(1):459-74
pubmed: 19889769
Hum Vaccin Immunother. 2013 May;9(5):1163-71
pubmed: 23377671
Vaccine. 2003 Apr 1;21 Suppl 1:S19-35
pubmed: 12628811
Virology. 1997 Aug 18;235(1):138-43
pubmed: 9300045
Virology. 1996 May 15;219(2):357-66
pubmed: 8638401
Front Cell Infect Microbiol. 2018 Aug 28;8:298
pubmed: 30234026
Folia Parasitol (Praha). 1991;38(3):275-82
pubmed: 1725516
Parasit Vectors. 2011 Apr 13;4:59
pubmed: 21489255
Emerg Microbes Infect. 2017 Sep 20;6(9):e82
pubmed: 28928417
J Virol Methods. 2007 Mar;140(1-2):115-23
pubmed: 17196266
Antiviral Res. 2019 Apr;164:23-51
pubmed: 30710567
Front Public Health. 2014 Dec 01;2:251
pubmed: 25520947
Emerg Infect Dis. 2002 Dec;8(12):1468-73
pubmed: 12498665
Virus Res. 2009 Mar;140(1-2):172-8
pubmed: 19111585
Acta Virol. 1963 Sep;7:434-6
pubmed: 14062331
Parasit Vectors. 2018 Aug 29;11(1):477
pubmed: 30153856
Genome Announc. 2016 Oct 20;4(5):
pubmed: 27795275
J Virol. 2010 Sep;84(17):8470-83
pubmed: 20554782
Ticks Tick Borne Dis. 2011 Dec;2(4):179-82
pubmed: 22108009
Parasitology. 2004;129 Suppl:S221-45
pubmed: 15938513
Vector Borne Zoonotic Dis. 2011 Jun;11(6):641-7
pubmed: 21548766
Schweiz Arch Tierheilkd. 1983 Jun;125(6):383-6
pubmed: 6612291
Antiviral Res. 2003 Jan;57(1-2):129-46
pubmed: 12615309
Viral Immunol. 2015 Jun;28(5):272-81
pubmed: 25695407
Vet Microbiol. 2010 Jan 27;140(3-4):221-8
pubmed: 19765917
Bull World Health Organ. 1967;36 Suppl:31-47
pubmed: 5298540
Euro Surveill. 2008 Apr 24;13(17):null
pubmed: 18445446
J Gen Virol. 2009 Aug;90(Pt 8):1781-94
pubmed: 19420159
PLoS One. 2013 Dec 13;8(12):e81214
pubmed: 24349041
BMC Vet Res. 2017 Aug 22;13(1):267
pubmed: 28830430
Virology. 1988 Sep;166(1):197-205
pubmed: 3413985
Acta Virol. 1995 Apr;39(2):95-8
pubmed: 7676942
Viruses. 2017 Dec 19;9(12):
pubmed: 29257111
Acta Pathol Microbiol Scand. 1966;66(4):489-509
pubmed: 5958418
Tsitologiia. 2017;59(3):199-209
pubmed: 30183184
J Med Virol. 1996 Jan;48(1):102-7
pubmed: 8825718
Vector Borne Zoonotic Dis. 2012 Mar;12(3):236-42
pubmed: 22022821
Viruses. 2017 Jul 13;9(7):
pubmed: 28703771
Viruses. 2019 Jul 22;11(7):null
pubmed: 31336624
Ann Parasitol. 2016;62(1):3-9
pubmed: 27262951
Eur J Neurol. 2017 Oct;24(10):1214-e61
pubmed: 28762591
Biochem Genet. 2012 Jun;50(5-6):440-7
pubmed: 22193288
Infect Genet Evol. 2017 Nov;55:159-165
pubmed: 28919548
Vet Microbiol. 2013 May 3;163(3-4):368-72
pubmed: 23395291
Experientia. 1993 Sep 15;49(9):802-5
pubmed: 8405306
Nature. 1956 Sep 15;178(4533):581-2
pubmed: 13369466
World Health Organ Tech Rep Ser. 1967;369:1-84
pubmed: 4963041
Vet Rec. 2002 Feb 16;150(7):218-20
pubmed: 11878442
Acta Virol. 1979 May;23(3):257-60
pubmed: 41440

Auteurs

Anna Michelitsch (A)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, 17493 Greifswald - Insel Riems, Germany.

Birke Andrea Tews (BA)

Institute of Infectology, Friedrich-Loeffler-Institut, Südufer 10, 17493 Greifswald - Insel Riems, Germany.

Christine Klaus (C)

Institute for Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institut, Naumburger Str. 96a, 07743 Jena, Germany.

Malena Bestehorn-Willmann (M)

Department of Parasitology, University of Hohenheim, Schloss Hohenheim 1, 70599 Stuttgart, Germany.

Gerhard Dobler (G)

Department of Parasitology, University of Hohenheim, Schloss Hohenheim 1, 70599 Stuttgart, Germany.
Bundeswehr Institute of Microbiology, German Center of Infection Research (DZIF) partner site Munich, Neuherbergstraße 11, 80937 München, Germany.

Martin Beer (M)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, 17493 Greifswald - Insel Riems, Germany.

Kerstin Wernike (K)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, 17493 Greifswald - Insel Riems, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH